| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $0.4B | $0.5B | $0.6B | $0.5B | $0.4B | $0.0B | $0.1B |
| EPS (Basic) | $1.02 | $0.70 | $0.95 | $1.14 | $1.13 | $0.94 | $0.10 | $0.22 |
| EPS (Diluted) | $1.01 | $0.69 | $0.95 | $1.14 | $1.12 | $0.93 | $0.10 | $0.22 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $64.1B | $62.5B | $60.9B | $57.5B | $43.4B | $40.7B | $37.4B | $31.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.4B |
| Total Liabilities | $56.3B | $55.1B | $54.2B | $51.1B | $38.4B | $36.1B | $33.1B | $28.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.8B | $7.4B | $6.7B | $6.4B | $5.1B | $4.6B | $4.4B | $3.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.5B | $0.4B | $1.4B | $0.8B | $0.2B | $1.5B | $0.6B |
| Investing Cash Flow | $-2.2B | $-0.7B | $-3.3B | $-6.8B | $-1.1B | $-2.0B | $-2.1B | $-3.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $1.5B | $1.2B | $2.9B | $4.3B | $1.0B | $2.8B | $0.7B | $2.5B |